Hematology

Resource Center

Featured

Sponsored
Sponsored
04/24/2026
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
04/24/2026
What's the Take Home?
What's the Take Home?
04/22/2026
Ronald N. Rubin, MD
A 55-year-old man was referred to the multispecialty practice by his primary physician for evaluation of pain in his hands and wrists.
04/22/2026
Sponsored
Sponsored
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026

Interactive Features

Photoclinic Challenge
Photoclinic Challenge
03/28/2026
Ashton L. Stahl
A full-term newborn presents with a fully formed, violaceous vascular lesion at birth. With imaging revealing mixed vascular flow and no postnatal proliferation, can you distinguish this rare entity from...
03/28/2026
Pop Quiz
Pop Quiz
10/14/2025
Miranda Manier, BA
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
10/14/2025
Pop Quiz
Pop Quiz
09/25/2025
Miranda Manier, BA
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
09/25/2025
Pop Quiz
Pop Quiz
08/13/2025
Anthony Calabro, MA
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
08/13/2025
3-in-30
3-in-30
06/26/2025
Miranda Manier, BA
Iron deficiency often goes unnoticed until symptoms interfere with daily life—or worse. Can you catch the clinical clues in time?
06/26/2025

Clinical Insights

Sponsored
Sponsored
04/24/2026
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
04/24/2026
Sponsored
Sponsored
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026
Sponsored
Sponsored
03/31/2026
In the final installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD interviews Tim F., a caregiver from Pittsburgh, PA, about the critical role caregivers play in shared...
03/31/2026
Sponsored
Sponsored
03/31/2026
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
03/31/2026
Expert Q&A
Expert Q&A
12/22/2025
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
12/22/2025